These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33610950)

  • 1. Neuroendocrine differentiation in a large series of genetically-confirmed Ewing's sarcoma family tumor: Does it provide any diagnostic or prognostic information?
    Machado I; Navarro S; López-Guerrero JA; Verdini L; Picci P; Giner F; Llombart-Bosch A
    Pathol Res Pract; 2021 Mar; 219():153362. PubMed ID: 33610950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer.
    Razvi H; Tsang JY; Poon IK; Chan SK; Cheung SY; Shea KH; Tse GM
    Pathology; 2021 Feb; 53(2):170-178. PubMed ID: 32951906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections.
    Mukhopadhyay S; Dermawan JK; Lanigan CP; Farver CF
    Mod Pathol; 2019 Jan; 32(1):100-109. PubMed ID: 30154579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: An immunohistochemical study with specificity analysis and comparison to chromogranin, synaptophysin, and CD56.
    Chen JF; Yang C; Sun Y; Cao D
    Pathol Res Pract; 2020 Jun; 216(6):152993. PubMed ID: 32381384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INSM1 Is Less Sensitive But More Specific Than Synaptophysin in Gynecologic High-grade Neuroendocrine Carcinomas: An Immunohistochemical Study of 75 Cases With Specificity Test and Literature Review.
    Zou Q; Zhang L; Cheng Z; Guo X; Cao D
    Am J Surg Pathol; 2021 Feb; 45(2):147-159. PubMed ID: 33264139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulinoma-associated Protein 1 (INSM1) Expression in Small Cell Neuroendocrine Carcinoma of the Urinary Tract.
    Kim IE; Amin A; Wang LJ; Cheng L; Perrino CM
    Appl Immunohistochem Mol Morphol; 2020 Oct; 28(9):687-693. PubMed ID: 31876605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear Insulinoma-Associated Protein 1 Expression as a Marker of Neuroendocrine Differentiation in Neoplasms of the Breast.
    Seijnhaeve E; Galant C; Van Bockstal MR
    Int J Surg Pathol; 2021 Aug; 29(5):496-502. PubMed ID: 33426999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulinoma-associated protein 1 is a sensitive and specific marker for lung neuroendocrine tumors in cytologic and surgical specimens.
    Viswanathan K; Siddiqui MT; Borczuk AC
    J Am Soc Cytopathol; 2019; 8(6):299-308. PubMed ID: 31345782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Value of Insulinoma-Associated Protein 1 (INSM1) and Comparison With Established Neuroendocrine Markers in Pulmonary Cancers.
    Staaf J; Tran L; Söderlund L; Nodin B; Jirström K; Vidarsdottir H; Planck M; Mattsson JSM; Botling J; Micke P; Brunnström H
    Arch Pathol Lab Med; 2020 Sep; 144(9):1075-1085. PubMed ID: 31913660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56.
    Sakakibara R; Kobayashi M; Takahashi N; Inamura K; Ninomiya H; Wakejima R; Kitazono S; Yanagitani N; Horiike A; Ichinose J; Matsuura Y; Nakao M; Mun M; Nishio M; Okumura S; Motoi N; Ito T; Miyazaki Y; Inase N; Ishikawa Y
    Am J Surg Pathol; 2020 Jun; 44(6):757-764. PubMed ID: 32118626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Insulinoma-Associated Protein 1 (INSM1) and Orthopedia Homeobox (OTP) in Tumors with Neuroendocrine Differentiation at Rare Sites.
    Roy M; Buehler DG; Zhang R; Schwalbe ML; Baus RM; Salamat MS; Lloyd RV; Rosenbaum JN
    Endocr Pathol; 2019 Mar; 30(1):35-42. PubMed ID: 30523500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new immunohistochemical marker, insulinoma-associated protein 1 (INSM1), for Merkel cell carcinoma: Evaluation of 24 cases.
    Leblebici C; Yeni B; Savli TC; Aydın Ö; Güneş P; Cinel L; Şimşek BÇ; Yıldız P; Tuncel D; Kayahan S
    Ann Diagn Pathol; 2019 Jun; 40():53-58. PubMed ID: 31031215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulinoma-associated protein 1 is a sensitive and specific marker of neuroendocrine lung neoplasms in cytology specimens.
    Doxtader EE; Mukhopadhyay S
    Cancer Cytopathol; 2018 Apr; 126(4):243-252. PubMed ID: 29360191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity.
    Rooper LM; Sharma R; Li QK; Illei PB; Westra WH
    Am J Surg Pathol; 2017 Nov; 41(11):1561-1569. PubMed ID: 28719469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulinoma-associated protein 1 immunostaining on cytology specimens: an institutional experience.
    Rodriguez EF; Fite JJ; Chowsilpa S; Maleki Z
    Hum Pathol; 2019 Mar; 85():128-135. PubMed ID: 30502379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX11 is a sensitive and specific marker for pulmonary high-grade neuroendocrine tumors.
    Yu L; Dong Y; Xue J; Xu S; Wang G; Kuang D; Duan Y
    Diagn Pathol; 2022 Jan; 17(1):2. PubMed ID: 34996493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing's sarcoma family of tumors (ESFT).
    Machado I; López-Guerrero JA; Scotlandi K; Picci P; Llombart-Bosch A
    Virchows Arch; 2018 May; 472(5):815-824. PubMed ID: 29445891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulinoma-associated Protein 1 Expression and Its Diagnostic Significance in Female Genital Tract Neuroendocrine Carcinomas.
    Ting CH; Wang TY; Wu PS
    Int J Gynecol Pathol; 2021 Sep; 40(5):452-459. PubMed ID: 33323849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulinoma-associated Protein 1 (INSM1) in Thoracic Tumors is Less Sensitive but More Specific Compared With Synaptophysin, Chromogranin A, and CD56.
    Kriegsmann K; Zgorzelski C; Kazdal D; Cremer M; Muley T; Winter H; Longuespée R; Kriegsmann J; Warth A; Kriegsmann M
    Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):237-242. PubMed ID: 30358615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine Markers Insulinoma-Associated Protein 1, Chromogranin, Synaptophysin, and CD56 Show Rare Positivity in Adenocarcinoma Ex-Goblet Cell Carcinoids.
    Yang C; Gonzalez I; Zhang L; Cao D
    Gastroenterology Res; 2019 Jun; 12(3):120-127. PubMed ID: 31236152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.